Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.
BMJ
; 379: e072623, 2022 11 23.
Article
in En
| MEDLINE
| ID: mdl-36520715
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Embolism
/
Venous Thrombosis
/
Venous Thromboembolism
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
BMJ
Journal subject:
MEDICINA
Year:
2022
Document type:
Article
Affiliation country: